Yueh-Chang Lee1, Jen-Hung Wang2, Tzu-Lun Huang3, Rong-Kung Tsai4. 1. Department of Ophthalmology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan. 2. Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Department of Health Administration, Tzu Chi College of Technology, Hualien, Taiwan. 3. Department of Ophthalmology, Far Eastern Memorial Hospital, Banciao District, New Taipei City, Taiwan; Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan. 4. Institute of Eye Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan. Electronic address: tsai.rk@gmail.com.
Abstract
PURPOSE: To investigate the incidence and prevalence of nonarteritic anterior ischemic optic neuropathy (NAION), and to extrapolate the risk of cerebrovascular events following NAION. DESIGN: Retrospective cohort study. METHODS: We identified NAION patients first, and then looked for the diagnosis of stroke after the diagnosis of NAION. SETTING: The study group was composed of patients diagnosed with NAION seeking ambulatory care from 2000 to 2011. The control group was extracted from a database by randomly selecting 2 patients for every NAION patient, matched by age and sex. MAIN OUTCOME MEASURES: Cox proportional hazards regression analysis was performed to calculate adjusted hazard ratio (aHR) of stroke for the 2 groups. Subgroup analysis of subjects with or without comorbidities was also investigated. RESULTS: Four hundred and fourteen patients were included in the study group and 789 in the control group. The mean follow-up period was 5.9 years. The incidence of NAION was 3.72/100 000 person-years in Taiwan, and the prevalence of NAION was 48.18/100 000 persons. The study group was more likely to have ischemic stroke (aHR = 2.03, P = .003), but not hemorrhagic stroke (aHR = 1.24, P = .696), than the control group. Among the subgroup with comorbidities, the risk of ischemic stroke among the subjects with NAION was 3.35 times higher than those without NAION (95% confidence interval: 1.67, 6.70). CONCLUSIONS: Patients with NAION have an increased risk of ischemic stroke. Physicians should refer all patients with NAION for systemic survey of vasculopathy and control of modifiable risk factors to prevent irreversible neurological sequelae.
PURPOSE: To investigate the incidence and prevalence of nonarteritic anterior ischemic optic neuropathy (NAION), and to extrapolate the risk of cerebrovascular events following NAION. DESIGN: Retrospective cohort study. METHODS: We identified NAIONpatients first, and then looked for the diagnosis of stroke after the diagnosis of NAION. SETTING: The study group was composed of patients diagnosed with NAION seeking ambulatory care from 2000 to 2011. The control group was extracted from a database by randomly selecting 2 patients for every NAIONpatient, matched by age and sex. MAIN OUTCOME MEASURES: Cox proportional hazards regression analysis was performed to calculate adjusted hazard ratio (aHR) of stroke for the 2 groups. Subgroup analysis of subjects with or without comorbidities was also investigated. RESULTS: Four hundred and fourteen patients were included in the study group and 789 in the control group. The mean follow-up period was 5.9 years. The incidence of NAION was 3.72/100 000 person-years in Taiwan, and the prevalence of NAION was 48.18/100 000 persons. The study group was more likely to have ischemic stroke (aHR = 2.03, P = .003), but not hemorrhagic stroke (aHR = 1.24, P = .696), than the control group. Among the subgroup with comorbidities, the risk of ischemic stroke among the subjects with NAION was 3.35 times higher than those without NAION (95% confidence interval: 1.67, 6.70). CONCLUSIONS:Patients with NAION have an increased risk of ischemic stroke. Physicians should refer all patients with NAION for systemic survey of vasculopathy and control of modifiable risk factors to prevent irreversible neurological sequelae.
Authors: Josep Callizo; Nicolas Feltgen; Antje Ammermann; Janina Ganser; Sebastian Bemme; Thomas Bertelmann; Sebastian Pfeiffer; Andre Duvinage; Klaus Gröschel; Hans Hoerauf; Rolf Wachter Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240
Authors: Min Seok Kim; Han Yeong Jeong; Kwan Hyuk Cho; Seung Won Oh; Seong Jun Byun; Se Joon Woo; Hee Kyung Yang; Jeong Min Hwang; Kyu Hyung Park; Chi Kyung Kim; Sang Jun Park Journal: PLoS One Date: 2019-11-14 Impact factor: 3.240
Authors: Robert C Foster; M Tariq Bhatti; Olivia M Crum; Elizabeth R Lesser; David O Hodge; James P Klaas; John J Chen Journal: J Neuroophthalmol Date: 2020-09 Impact factor: 3.042